Forum Topic News
  • Conversation: Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash

    • July 3, 2018 1:00 PM BST
    • Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash

      Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has commenced a cash tender offer for all of the outstanding shares of common stock of Foundation Medicine, Inc. (NASDAQ: FMI) at a price of US$ 137.00 per share. The tender offer is being made pursuant to the previously announced merger agreement dated as of 18 June 2018 among Foundation Medicine, Inc., Roche Holdings, Inc., an indirect wholly owned subsidiary of Roche Holding Ltd, and 062018 Merger Subsidiary, Inc., a wholly owned subsidiary of Roche Holdings, Inc. The tender offer period will expire at 12am midnight, Eastern Time, at the end of the day on 30 July 2018, unless the offer is extended.
      Roche has filed a tender offer statement on Schedule TO with the United States Securities and Exchange Commission (SEC). 062018 Merger Subsidiary, Inc. is the acquirer in the tender offer. The Offer to Purchase contained within the Schedule TO sets out the terms and conditions of the tender offer.
      Read more: http://www.worldpharmanews.com/roche/4466-roche-commences-tender-offer-for-all-shares-of-foundation-medicine-inc-for-us-137-00-per-share-in-cash

Add Reputation

Do you want to add reputation for this member by this post?

or cancel
‚Äč